Nanotherapeutics Secures $30 Million Loan Facility from Hercules Technology Growth Capital

ALACHUA, Fla., Jun 03, 2014 (BUSINESS WIRE) — Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, announced today that it has secured a $30 million loan facility from Hercules Technology Growth Capital, Inc. HTGC, -1.61% The funds from the loan facility will support the Company’s efforts to expand its manufacturing infrastructure.

Nanotherapeutics’ core competencies are in development and cGMP manufacture of pre-clinical and clinical stage biopharmaceutical products. The Company provides a full range of drug development services and intends to further capitalize on its capabilities through partnerships with government and established companies, as well as continuing to fund the development of its internal pipeline.